Biocracked
Longevity Metabolism Peptides Research Supplements Trending: supplements clinical trial longevity nad+ nootropics
Approach: conceptual metaphor. Palette: bold color field. A single glass hourglass stands center-frame on a saturated tomato-red seamless backdrop, photographed at a low three-quarter angle just above tabletop level. The upper chamber holds only a thin layer of pale sand, while the lower chamber is heaped with it. A narrow stream of fine grains falls through the neck, and a few of them glow faintly electric green (#00e676) as they pass the waist. Beside it, a second hourglass has been tipped onto its side, its sand motionless. This stands for the age cutoff. Soft, large-source studio light comes from the upper left and casts crisp, warm-grey shadows on the glossy red surface. Fine scratches and dust show on the glass. The shallow depth of field blurs the background hourglass slightly. The mood is playful but precise, curious and a little skeptical.
Supplements

2 g Carnosine Nambah Kecepatan Otak, Tapi Mung Ing Wong Umur 23–35 Taun

Nova Chen · · 4 min read
#supplements #beta alanine #carnosine #clinical trial #brain health #cognition #nootropics

2 g Carnosine Nambah Kecepatan Otak, Tapi Mung Ing Wong Umur 23–35 Taun

Ringkesan: Percobaan sing sengaja digawé kanggo nguji perlindungan saka polusi udhara malah nemokaké temuan aneh babagan carnosine lan fungsi otak. Ing wong diwasa umur 23–35 taun, 2 g carnosine saben dina nganti 12 minggu ana hubungané karo peningkatan kecepatan lan efisiensi kognitif, nanging kelompok umur luwih tuwa ora nampa manfaat sing berarti. Temuan iki asalé saka analisis post‑hoc sub‑kelompok saka trial acak sing melu 299 wong. Ing ngisor iki bakal dijlèntrèhaké apa sing ditemokaké ing trial NEAT, bedané carnosine karo beta‑alanine, lan sapa sing kudu (lan ora kudu) nggatekaké iki.

Suplemen asam amino sing regané terjangkau bisa nambah kecepatan mental ing wong diwasa sehat

Para peneliti sing nliti data saka trial acak lan kontrol plasebo nemokaké menawa 2 g carnosine saben dina ana hubungane karo peningkatan kecepatan lan efisiensi kognitif ing wong diwasa umur 23–35 taun. Kelompok umur 36–50 lan 51–65 taun mung entuk perbaikan sekedhik utawa ora ana babar pisan. Artikel iki ngutip tulisan ing Neurotherapeutics taun 2025 saka tim University of Louisville sing mimpin trial NEAT.

Sadurunge njupuk suplemen apa wae, ayo dhisik dicritakake apa sing diteliti lan apa sing ora.

Twist‑nya: riset otak sing kebabar ing trial polusi

Uraian kognitif dudu tujuan utama percobaan iki. Studi induk, Nucleophilic Defense Against PM Toxicity (NEAT) trial (NCT03314987), dirancang kanggo nguji apa carnosine isa ngurangi dampak partikel (particulate matter) sing mbebayani ing polusi udhara. Carnosine iku dipeptida nukleofilik, molekul sing bisa netralisir spesies reaktif asil stres oksidatif – mulane dipilih dadi agen potensial nglawan toksisitas polusi.

Pengukuran kognitif ditambahaké minangka post‑hoc secondary outcome. Sawisé trial rampung, peneliti mriksa kinerja otak lan ngitung bobot temuan (bakal dibahas mengko).

Carane trial iki dilakokaké

  • Desain: Randomized, placebo‑controlled clinical trial
  • Intervensi: Kapsul carnosine 2 g saben dina vs. plasebo beras jagung
  • Durasi: nganti 12 minggu
  • Peserta: 299 wong dirandomisasi. Data kognitif sing layak dipigunakaké asalé saka 242 wong ing kontrol minggu 6 lan 231 wong ing kontrol minggu 12
  • Strata umur: 23–35, 36–50, lan 51–65 taun
  • Instrumen kognitif: Cognition test battery, sepuluh tes individu sing saben‑saben nyasarake domain otak béda. Kecepatan, akurasi, lan efisiensi dinilai sacara gabungan lan per‑tes.
  • Jadwal testing: Baseline sadurunge randomisasi, banjur kira‑kira minggu 6 lan 12 sasampuné suplementasi

Populasi iki unik amarga ora ana faktor risiko utawa penyakit kronis sing wis ana. Mayoritas peserta bébas saka faktor kerentanan kognitif. Penelitian sadurungé nyaranaké yèn carnosine utawa beta‑alanine bisa mbantu wong tuwa utawa kelompok berisiko, nanging trial iki nggunakaké kelompok sing umume sehat.

Apa sing ditemokaké

Nalika peneliti misahaké peserta miturut umur, kelompok paling enom (23–35 taun) sing paling negesaké:

  • Peningkatan statistik sing signifikan ing kecepatan lan efisiensi sakabèhé ing loro kunjungan kontrol.
  • Peningkatan signifikan ing pitu saka sepuluh tes (kecepatan utawa akurasi).
  • Kelompok umur luwih tuwa mung entuk pembaruan sing sekedhik utawa ora ana.

Penulis nyimpulaké yèn carnosine "selektif nambah performa kognitif tingkat tinggi ing individu enom."

Nanging abstrak ora nyedhiyakake ukuran efek (effect size) utawa ukuran sampel per grup, dadi ora cetha sepira gedhéné perbaikané. "Statistik signifikan" ora ateges sampeyan bakal krasa béda ing urip saben dina.

Napa pola umur iki aneh, lan kenapa kudu skeptis

Umume antusiasme babagan carnosine ditujokaké kanggo wong tuwa utawa kelompok berisiko, amarga fungsi otak kang mudhun maringi ruang gedhé kanggo perbaikan. Manfaat sing mung katon ing wong enom bertentangan karo pangarep‑arep iki.

Alesan kanggo waspada:

  1. Analisis post‑hoc secondary. Trial ora dirancang kanggo njawab pitakonan kognitif.
  2. Temuan sub‑kelompok. Nggedhekaké trial dadi telung rentang umur lan nguji akèh outcome nambah risiko asil kebetulan. Abstrak ora nerangaké cara ngatasi perbandingan ganda.
  3. Mekanisme durung dibuktekake. Abstrak ora nerangaké kenapa otak enom bakal nanggapi béda.
  4. Butuh konfirmasi. Trial sing dirancang khusus karo kognisi minangka outcome utama lan nggatekaké efek umur bakal luwih valid.

Mula, asil iki kudu dianggep minangka hipotesis sing pantes diuji, dudu rekomendasi klinis.

Carnosine vs. beta‑alanine: apa bedane?

Carnosine iku dipeptida sing dumadi saka loro asam amino, beta‑alanine lan histidine. Carnosine ana sacara alami ing otot, jaringan otak, lan uga ing daging lan iwak.

Beta‑alanine mung salah siji saka loro prekursor mau, lan dadi faktor pembatas ing sintesis carnosine ing otot. Mulane beta‑alanine asring dipigunakaké ing suplemen olahraga supaya nambah cadangan carnosine otot. Efek samping sing paling dikenal yaiku paresthesia (rasa kesemutan) sing ora mbebayani, mula dosis dijaga supaya ora gedhé.

Trial NEAT nguji carnosine secara langsung, ora beta‑alanine. Apa beta‑alanine bakal ngasilaké efek kognitif sing padha ora dibahas ing riset iki, lan nambah carnosine otot ora padha karo nambah carnosine ing otak.

Apa artiné kanggo sampeyan

  • Dosis sing diteliti: 2 g carnosine saben dina, nganti 12 minggu. Iki siji‑sijine regimen sing duwé data ndhukung temuan iki. Abstrak ora nyebutake cara ngonsumsi (pagi, sore, utawa dibagi), mula ora ana saran timing adhedhasar bukti.
  • Sapa sing bisa tertarik: Wong diwasa sing sehat lan umur 23–35 taun sing kepengin nyoba, nanging tetep disaranake rembugan dhisik karo dhokter.
  • Sapa sing ora bakal entuk manfaat gedhé: Wong sing umure luwih saka 35 taun. Ing analisis iki, grup umur 36–50 lan 51–65 ora nuduhaké peningkatan signifikan.
  • Sapa sing kudu ngindhari utawa takon dhisik karo dokter: Wanita hamil utawa nyusui, wong sing ngonsumsi obat, lan sing nduwèni kondisi kronis. Populasi trial mayoritas sehat, dadi keamanan kanggo kelompok liya durung cetha.
  • Alternatif sing luwih mirah: Beta‑alanine umume luwih murah lan konsisten nambah carnosine otot. Nanging iki senyawa sing beda, durung kabukten ningkataké kognisi, lan bisa nyebabaké rasa kesemutan. Anggep iki minangka eksperimen sing kapisah, dudu substitusi sing wis terbukti manfaaté kanggo otak.
  • Ekspektasi realistis: Ora ana bukti sing nuduhaké carnosine iku "pil pintar". Penulis ngetokaké yèn manfaat sing dideteksi mung ana ing tes laboratorium kanggo sub‑kelompok cilik.

Kesimpulan

Trial acak sing dirancang kanggo sinau efek polusi udhara nampilaké temuan sampingan sing mengejutaké. Dua gram carnosine saben dina nganti 12 minggu dikaitaké karo kinerja sing luwih cepet lan efisien ing tes kognitif kanggo wong diwasa umur 23–35 taun, nanging pengaruhé minimal kanggo kelompok umur luwih tuwa. Iki menarik, nanging asalé saka analisis post‑hoc sub‑kelompok. Nganti ana trial khusus sing ngonfirmasi, anggep iki minangka petunjuk sing pantes diteliti luwih lanjut, dudu alesan kanggo ngowahi rutinitasmu saiki.

Original study

Read the original research on pubmed.ncbi.nlm.nih.gov →

This article summarizes published research for general information. It is not medical advice.

Share XFacebookLinkedInRedditWhatsApp
NC

Written by

Nova Chen

Nova Chen writes for Biocracked: biohacking science, longevity & human performance.

Related Articles

Approach 4, conceptual metaphor, in palette C, natural. A single ceramic cup of freshly brewed green tea sits on a weathered wooden windowsill, photographed from a low three-quarter angle at eye level. Steam curls upward and catches soft, directional morning daylight from a window on the left. The tea is clear amber-green, with a few loose unfurled tea leaves resting on the saucer. Behind the cup, a softly out-of-focus garden of leafy green plants and a bright, hazy sky gives shallow depth of field. The wood has realistic grain and small chips, and the ceramic has a matte, slightly speckled glaze. A single tea leaf in the foreground has a faint electric green tint where light passes through it. The mood is calm, quiet and unhurried, with warm skin-tone wood against cool plant greens. No text, no labels.
supplements

L‑Theanine Tanpa Ngantuk: Dosis Sing Saktenane Efektif

BY NOVA CHEN ·

L‑theanine, asam amino sing ditemokaké ing téh, dianggep bisa nenangaké tanpa nimbulaké rasa ngantuk. Review cilik saka *Frontiers in Nutrition* nyoba ngétung klaim kuwi adhedhasar uji coba manungsa. Dosis 100‑400 mg dilaporaké kanggo peningkatan kognitif sing alit (utamane yen bareng kafein), 200‑400 mg saben dina kanggo ngurangi stres tanpa ngantuk, lan 200‑450 mg saben dina kanggo ningkataké kualitas turu. Pengaruhé cilik lan ora ana ukuran sampel gabungan sing dicantumaké. Loro penulisé kerja kanggo anak perusahaan British American Tobacco sing ngedol produk L‑theanine.
Approach: conceptual metaphor. Palette: D, bold color field. A single brass dial-style dosing syringe-free metaphor: a tall glass measuring cylinder, photographed straight on at eye level, filled with clear liquid and a column of stacked white tablets that rises in even steps and then stops short of a thin painted line, as if a staircase of doses has been held back. The glass cylinder stands on a glossy surface against a saturated tomato-red seamless backdrop. Soft large-softbox light from the left gives crisp highlights on the glass and a clean, short shadow on the right. A tiny electric green (#00e676) rubber band circles the cylinder near the top limit. Shallow depth of field blurs a second, taller cylinder in the background. Mood: controlled, restrained, quietly hopeful. No text, no markings legible.
supplements

Magtein Nguwasi Lonjakan Dosis Opioid ing Pasien Kanker? Apa Sing Ditemokaké Ing Penelitian

BY NOVA CHEN ·

Suplemen magnesium sing paling misuwur kanggo ningkataké memori lan turu iki saiki muncul ing uji klinis nyeri kanker. Ing 83 pasien kanker stadium lanjut sing nggunakake opioid oral, sing njupuk magnesium‑L‑threonate (L‑TAMS, senyawa sing dipasaraké minangka Magtein) mung nambah dosis morfin separo saka sing njupuk plasebo sajroning 90 dina. Suplemen iki uga nyuda konstipasi sing disebabaké opioid. Nanging iki mung studi cilik ing siji pusat lan populasi sing khusus, mula ora dadi alesan kanggo ngowahi obat tanpa pitutur dhokter. Ing ngisor iki apa sing ditemokaké, apa sing ora, lan sapa sing kudu rembugan karo klinisi.
Approach: conceptual metaphor. Palette: D, bold color field. A single AA-style cylindrical battery stands upright, fully charged, on a seamless saturated mustard-yellow backdrop. Beside it sits a matching, untouched, slightly dusty glass jar of marbles, so the charge shows no visible link to any result. More precisely, a bright tomato-red extension cord plugs into the battery's top. Its other end curls away unconnected, lying on the floor beside an unlit incandescent bulb. A small electric green LED glows on the battery's side as the only green accent. Camera: low three-quarter angle, 50mm lens, shallow depth of field, with the bulb softly blurred in the foreground. Lighting: hard, clean studio key light from the upper left, with crisp shadows falling to the right on the yellow surface. Mood: puzzled, wry, a full power source that fails to light anything.
supplements

Nicotinamide Riboside Nggedhekake NAD+ Kapindho Nanging Gagal Nambah Memori

BY NOVA CHEN ·

Suplemen iki nambahake tingkat molekul kunci ing getih nganti kapindho, nanging ora ana peningkatan ing memori. Ing uji coba acak 12 minggu marang wong tuwa sing duwe amnestic mild cognitive impairment, nicotinamide riboside munggahake NAD+ loro kaping nanging ora ngowahi kognisi, aliran getih otak total, utawa tekanan darah. Ana siji petunjuk eksploratori babagan aliran getih ing hippocampus, nanging isih adoh saka bukti kuat. Ing ngisor iki apa sing dituduhake studi iki, watesane, lan apa tegese yen sampeyan mikir arep tuku NAD+ booster.
**Approach: Conceptual metaphor. Palette: D, bold color field.** A saturated mustard-yellow seamless backdrop. In the center, shot from a slightly high three-quarter angle, a single old brass balance scale stands on a matte surface. One pan holds a small, glossy, translucent green glass sphere with a faint electric green (#00e676) glow inside, standing for the peptide's promise. The other pan holds a plain grey stone of similar size. The beam is almost level but tilts slightly toward the green side, so the result looks real but not decisive. Hard, directional studio light from the upper left casts crisp, defined shadows across the yellow. Fine scratches and patina show on the brass. The background is clean and the framing is wide, with open space on the right. The mood is curious, skeptical and balanced.
peptides

Peptida Otak N‑PEP‑12: Peningkatan Memori Sajrone 90 Dina, Nanging Ana Gotong

BY NOVA CHEN ·

Sebuah uji acak kanthi 276 peserta sing nampa suplemen peptida N‑PEP‑12 nuduhaké yèn skor perhatian wiwit béda karo plasebo sak suwéné wektu ing wong diwasa umur 50‑75 taun sing ngeluh babagan memori lan konsentrasi. Ing 90 dina, loro grup dosis 45 mg lan 90 mg loro‑loro nuduhaké peningkatan sing luwih gedhé ing kewaspadaan, atensi lan memori, lan uga skor Digit Span sing nambah. Nanging, efek utama perawatan ora signifikan (p = 0.133) lan temuan ing titik akhir tetep dijenengi eksploratif. Efek samping jarang lan rata antar grup. Kene apa sing dituduhaké data, sapa sing cocok, lan apa sing isih durung ana.

This page is available in

English العربيةবাংলাČeštinaDeutschEspañolفارسیFrançaisHausaहिन्दीHrvatskiBahasa IndonesiaItaliano日本語Basa Jawa한국어NederlandsਪੰਜਾਬੀPolskiPortuguêsRomânăРусскийSrpskiTürkçeУкраїнськаTiếng Việt中文